Cost Containment Achieved with Valenz Bluebook Rx

This case study outlines how a Fortune 500 company implemented the Valenz Bluebook Rx solution to reduce its pharmacy spending significantly. The company, which employs 8,000 individuals, faced rising health plan costs, particularly in pharmaceutical expenses. An analysis of their pharmacy benefits program revealed that a single drug was costing over $500,000 annually, along with notable price variances in mail order medications. To address these challenges, the Valenz Bluebook Rx solution was deployed, enrolling members in a pharmacy benefits management program that promoted the use of lower-cost, clinically equivalent medications. This initiative not only encouraged members to choose more affordable options through reduced copays and savings coupons but also allowed the client to negotiate better terms with their pharmacy benefit manager by identifying overspending. As a result, the company achieved total savings of $13.5 million over five years, translating to an average savings of $1,312 per enrolled employee each year.